Skip to content
PICO Portalanswers from OpenAlex

Use of surrogate endpoints in health technology assessment and reimbursement of treatments for the management of chronic kidney disease

PaperCitations, authors & open-access status

Use of surrogate endpoints in health technology assessment and reimbursement of treatments for the management of chronic kidney disease is a paper indexed in PICO Portal from OpenAlex.

How many citations does Use of surrogate endpoints in health technology assessment and reimbursement of treatments for the management of chronic kidney disease have?

PICO Portalcitation count

Use of surrogate endpoints in health technology assessment and reimbursement of treatments for the management of chronic kidney disease has 6 citations in the OpenAlex counts PICO Portal stores.

When was Use of surrogate endpoints in health technology assessment and reimbursement of treatments for the management of chronic kidney disease published?

PICO Portalyear

Use of surrogate endpoints in health technology assessment and reimbursement of treatments for the management of chronic kidney disease has 2025 year in the PICO Portal index.

What is the open-access status of Use of surrogate endpoints in health technology assessment and reimbursement of treatments for the management of chronic kidney disease?

PICO Portaloa status

Use of surrogate endpoints in health technology assessment and reimbursement of treatments for the management of chronic kidney disease has gold oa status in the PICO Portal index.

What is the DOI of Use of surrogate endpoints in health technology assessment and reimbursement of treatments for the management of chronic kidney disease?

PICO Portaldoi

The DOI for Use of surrogate endpoints in health technology assessment and reimbursement of treatments for the management of chronic kidney disease is on the source record.

What is the PMID of Use of surrogate endpoints in health technology assessment and reimbursement of treatments for the management of chronic kidney disease?

PICO Portalpmid

The PMID for Use of surrogate endpoints in health technology assessment and reimbursement of treatments for the management of chronic kidney disease is on the source record.

What is the OpenAlex record for Use of surrogate endpoints in health technology assessment and reimbursement of treatments for the management of chronic kidney disease?

PICO Portalopenalex

The OpenAlex for Use of surrogate endpoints in health technology assessment and reimbursement of treatments for the management of chronic kidney disease is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial